Fibromatosis arising from the breast, also referred to as desmoid tumor, aggressive fibromatosis, or lowgrade fibrosarcoma, is a rare benign entity, accounting for only 0.2% of all breast tumors. Associations with familial multicentric fibromatosis and trauma, including that resulting from surgical intervention, have been reported. Awareness of this lesion is important, as the diagnosis has often been confused with that of breast carcinoma. We present the case of a 30-year-old white woman who presented with a palpable mass within the medial portion of her right breast. She reported breast carcinoma in both her paternal grandmother and maternal aunt. Subsequent mammographic and sonographic evaluation demonstrated an irregular solid mass within the posteromedial portion of the right breast. Ultrasound-guided core needle biopsy revealed low-grade myofibroblastic proliferation consistent with breast fibromatosis. The lesion was surgically resected via wide local excision. Follow-up mammograms performed 1 and 2 years after resection demonstrated no radiographic evidence of recurrence.
CASE REPORT
A 30-year-old white woman presented to Baylor University Medical Center at Dallas (BUMC) with a palpable mass in the medial portion of her right breast. Past medical history disclosed migraine headaches. Breast carcinoma had occurred in her paternal grandmother at age 58 and maternal aunt at age 52. She reported the onset of menarche at age 11 and had never been pregnant.
Bilateral diagnostic mammogram at BUMC demonstrated an ill-defi ned 2-cm mass at the 3 o'clock position at the palpable area of concern within the right breast. Associated distortion and tenting of the underlying pectoralis muscle were also noted (Figures 1 and 2) . Subsequent sonographic evaluation of the right breast demonstrated a 1.9 × 1.6 cm irregular hypoechoic lesion extending to the pectoralis muscle at the 3 o'clock position of the right breast, 9 cm from the nipple (Figure 3) .
Th e patient underwent a sonographic-guided core needle biopsy of the lesion, which demonstrated a low-grade myofi bro- blastic proliferation consistent with breast fi bromatosis (Figure 4) . Th e patient subsequently underwent wide local excision of the lesion from the right breast and subsequent bilateral mammoplasty. Follow-up mammograms performed at 1 and 2 years following the excision demonstrated no evidence of lesion recurrence.
DISCUSSION
Fibromatosis arising from the breast, also referred to as desmoid tumor, low-grade fi brosarcoma, or aggressive fi bromatosis, is a rare benign entity characterized histologically by low-grade spindle cell proliferations composed of interlacing fi broblastic bundles and fascicles with varying degrees of b a collagen. Th e lesions are noted to have irregular, fi nger-like margins, with spindle cells infi ltrating and surrounding normal breast parenchyma. Grossly, the lesion appears as a rubbery, poorly vascularized grayish-white mass (1-3). Although cellular atypia may be present, the spindle cells are typically uniform with a low mitotic index (1, 4) . Th e histopathologic diff erential diagnosis includes scar formation, fi brosarcoma, and fi bromatosis-like metaplastic spindle cell tumor (4).
Fibromatosis is a benign entity without metastatic potential but carries a signifi cant risk for local recurrence (5) . It accounts for only 0.2% of all breast tumors and 0.3% of all solid tumors (4) . Th e calculated lesion occurrence at BUMC is also 0.2% of all breast tumors. Between January 1, 2009, and March 31, 2011, there were four documented cases of breast fi bromatosis among the 2174 breast tumors biopsied. Th e patients ranged in age from 13 to 83 years. Most cases occurred in young, premenopausal women, but cases have also been reported in men (3, 4, 6) .
Th e etiology of this lesion is not well understood, but an association with Gardner's syndrome was initially delineated in 1964 in the fi rst reported case of breast fi bromatosis (3, 7). Since then, few cases of breast fi bromatosis have been associated with Gardner's syndrome. Additional associations include familial multicentric fi bromatosis, silicone and saline breast implants, and incidental and surgical trauma (1, 4) .
Although some reports have suggested an association with sex steroid hormones, a 2000 study by DevouassouxShisheboran et al refuted this association. Of the 33 reported cases of breast fi bromatosis in their study, only one case demonstrated estrogen receptor (ER) and progesterone receptor (PR) positivity within a tumor localized to the chest wall (8) . Similarly, a case study performed by Reis-Filho et al assessed the immunohistochemical expression of ER and PR in one patient who developed simultaneous mammary fi bromatosis and abdominal fi bromatosis. While cells from the abdominal desmoid tumor specimen demonstrated immunoreactivity for both receptors, the cells from the primary breast tumor were deemed negative (9) .
Clinically, desmoid tumors of the breast present as fi rm, painless, movable masses, and skin retraction and/or dimpling may be present. Nipple retraction is often seen in tumors that are close to the nipple. Nipple discharge and palpable lymphadenopathy are not associated with breast fi bromatosis. Desmoid tumors are often irregularly shaped, high-density lesions with spiculated margins that closely mimic breast carcinoma on mammography. Rarely do these tumors demonstrate calcifi c deposition. Sonographically, breast fi bromatosis presents as a poorly defi ned, hypoechoic mass with posterior acoustic shadowing and an echogenic rim, fi ndings that make it indistinguishable from breast cancer (3) (4) (5) 10) . Desmoid tumors are heterogeneous on magnetic resonance imaging and may be hypointense to isointense on T1-weighted images and hypointense to hyperintense on T2-weighted images. Moderate to strong enhancement is noted following the administration of intravenous contrast (10, 11) . Mutations of alterations in the adenomatous polyposis coli and beta-catenin pathway are implicated in the development of sporadic and familial adenomatous polyposis-associated breast fi bromatosis (4) .
Management of desmoid tumors includes wide local surgical excision despite high local recurrence rates ranging from 24% to 77% over the course of 10 years. Radiation therapy is used in patients with unresectable tumors or lesions that would require extensive surgical resection, to include amputation or major chest or abdominal wall resection. Medical therapy for breast fi bromatosis includes three major classes of drugs: hormonal agents, antiinfl ammatory agents, and cytotoxic agents (2) .
